• Users Online: 559
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Browse Articles Search Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2015  |  Volume : 6  |  Issue : 1  |  Page : 89

Trend in prevalence of hepatitis C virus infection among ß-thalassemia major patients: 10 years of experience in Iran


1 Department of Hematology/Oncology, Guilan University of Medical Sciences, Rasht, Iran
2 Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran; Department of Neurobiology, Care Science and Society (NVS), H1, Division of Family Medicine, Karolinska Institutet, Sweden, Sweden
3 Guilan Road Trauma Research Center, Guilan University of Medical Sciences, Rasht, Iran
4 Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran

Correspondence Address:
Ali Davoudi-Kiakalayeh
Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran
Sweden
Login to access the Email id

Source of Support: We would like to thank the Guilan blood transfusion organization for financial support of this study, Conflict of Interest: None


DOI: 10.4103/2008-7802.164832

Rights and Permissions

Background: Hepatitis C virus (HCV) is the leading cause of transfusion transmitted infections (TTIs) among patients with b-thalassemia major. A high prevalence of HCV was reported among these patients. The aim of this study is seeking the trend of the prevalence of HCV infection among the patients with b-thalassemia major in Guilan province, Northern Iran over a 10-year period. Methods: A retrospective study was conducted on 1113 patients with b-thalassemia major in the Guilan province, northern Iran from 2002 to 2012, using multiple data sources. A blood sample was taken from each patient, and a questionnaire regarding demographic data and risk factors was completed for them. Enzyme-linked immunosorbent assay and recombinant immunoblot assay for HCV were performed in all cases. A stepwise forward logistic regression analysis was done. Results: The prevalence of hepatitis C infection among b-thalassemia major patients was 13.6%. The risk of hepatitis C among b-thalassemia major patients was greater before screening program for HCV (odds ratio = 9.6, 95% confidence interval: 2.3-40.5). In addition, the prevalence of anti-HCV seropositivity was decreased dramatically among patients who have received transfusions after implementation of blood donor screening for HCV. There were no positive HCV cases in the patients younger than 10 years. Conclusions: The risk of TTIs including HCV can be reduced by implementing screening program for healthy blood.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1831    
    Printed29    
    Emailed0    
    PDF Downloaded232    
    Comments [Add]    
    Cited by others 18    

Recommend this journal